View in EDS

Pharmaceutical assessment of low global warming potential alternatives to HFA-134a in a budesonide, glycopyrrolate, and formoterol fumarate pressurized metered-dose inhaler.

Saved in:
Bibliographic Details
Title: Pharmaceutical assessment of low global warming potential alternatives to HFA-134a in a budesonide, glycopyrrolate, and formoterol fumarate pressurized metered-dose inhaler.
Authors: Lachacz K; Global Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, Sweden. Electronic address: kellisa.lachacz@astrazeneca.com., Kaye R; Pharmaceutical Technology & Development, Operations, AstraZeneca, Cambridge, UK., Mello L; Global Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Durham, NC, USA., Stoker A; Global Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Durham, NC, USA., Törnell J; Global Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, Sweden.
Source: Journal of pharmaceutical sciences [J Pharm Sci] 2026 Oct; Vol. 115 (10), pp. 104458. Date of Electronic Publication: 2026 Aug 12.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 2985195R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-6017 (Electronic) Linking ISSN: 00223549 NLM ISO Abbreviation: J Pharm Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42586434
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pharmaceutical assessment of low global warming potential alternatives to HFA-134a in a budesonide, glycopyrrolate, and formoterol fumarate pressurized metered-dose inhaler.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lachacz+K%22">Lachacz K</searchLink>; Global Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, Sweden. Electronic address: kellisa.lachacz@astrazeneca.com.<br /><searchLink fieldCode="AU" term="%22Kaye+R%22">Kaye R</searchLink>; Pharmaceutical Technology & Development, Operations, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Mello+L%22">Mello L</searchLink>; Global Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Stoker+A%22">Stoker A</searchLink>; Global Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Törnell+J%22">Törnell J</searchLink>; Global Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, Sweden.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%222985195R%22">Journal of pharmaceutical sciences</searchLink> [J Pharm Sci] 2026 Oct; Vol. 115 (10), pp. 104458. <i>Date of Electronic Publication: </i>2026 Aug 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>2985195R <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1520-6017 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200223549%22">00223549 </searchLink><i>NLM ISO Abbreviation: </i>J Pharm Sci <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42586434
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.xphs.2026.104458
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 104458
    Titles:
      – TitleFull: Pharmaceutical assessment of low global warming potential alternatives to HFA-134a in a budesonide, glycopyrrolate, and formoterol fumarate pressurized metered-dose inhaler.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lachacz K
      – PersonEntity:
          Name:
            NameFull: Kaye R
      – PersonEntity:
          Name:
            NameFull: Mello L
      – PersonEntity:
          Name:
            NameFull: Stoker A
      – PersonEntity:
          Name:
            NameFull: Törnell J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2026 Oct
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1520-6017
          Numbering:
            – Type: volume
              Value: 115
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Journal of pharmaceutical sciences
              Type: main
ResultId 1